| abstract |
Embodiments of the invention provide for cell therapy for cancers having a TEMl or TEM8 antigen. Certain embodiments provide for cell therapy that targets tumor vasculature, including the tumor vascular bed, for example. In specific embodiments, TEMl- and/or TEM8- specific chimeric antigen receptors are employed. |